Patent ID: 7837987

Claim:
A method for treating a mammalian patient having suffered an injury to its spinal cord or sciatic nerve, the method comprising administering an effective amount of a composition comprising at least one polyalkylene glycol selected from the group consisting of polmethylene glycol, polyethylene glycol, polypropylene glycol, polybutylene glycol, polypentylene glycol, polyhexylene glycol, polyheptylene glycol, polyoctylene glycol, polynonylene glycol, and polydecylene glycol, and branched and structural isomers thereof to the patient so that the polyalkylene glycol is delivered by way of the patient's vascular system to the site of the injured spinal cord or sciatic nerve tissue, wherein delivery by way of the patient's vascular system is effected using a technique selected from the group consisting of intravascular, intramuscular, subcutaneous, and intraperitoneal injection, and wherein the polyalkylene glycol is at least about 30% by weight in the composition.